Olympic Gold-Medal Winner, Adam van Koeverden, Teams Up With FLONASE® Allergy Relief This Allergy Season
Olympic kayaker with allergies zooms through Toronto in a car covered in flowers
MISSISSAUGA, ON, April 20, 2017 – It’s the beginning of allergy season in Canada, and Olympic kayaker, Adam van Koeverden, has teamed up with FLONASE® Allergy Relief to help Canadians find a better way to manage their symptoms. This is the first allergy season that Canadians can obtain FLONASE® Allergy Relief without a prescription.
van Koeverden will be travelling in a car covered in flowers today, specifically 4,000 daisies and carnations. He’ll be driving through Toronto’s downtown core, to show allergy sufferers what’s possible regardless of allergies.
“Having suffered from allergies for years and worrying about how they would affect my ability to kayak, I was looking for an option to help control my irritating symptoms,” said van Koeverden. “Now that FLONASE® Allergy Relief is available without a prescription, even more Canadians can use it and do the things they love without their allergy symptoms getting in the way.” Now, because he knows when his symptoms will start acting up, he just picks it up at the pharmacy.
A long-time seasonal allergy sufferer van Koeverden learned about FLONASE® Allergy Relief from his team doctor.
“For Canadians living with seasonal allergies, the burden goes beyond just a runny nose,” said Dr. Susan Waserman, allergist and McMaster University professor. “Allergy sufferers have problems sleeping and experience challenges concentrating. The good news is that FLONASE® Allergy Relief is now more readily available and provides reliable relief of allergy symptoms.”
About Seasonal Allergies
Seasonal allergic rhinitis (SAR), also known as seasonal allergies, affects at least 25 per cent of Canadians.1 Over 80 per cent of sufferers have sought medical attention to treat their symptoms1 however, 60 per cent reported their symptoms were only somewhat, poorly and not controlled.1 Fatigue, poor concentration and reduced productivity are some of the most common symptoms among nasal allergy sufferers.1 Nasal allergy symptoms can range in severity and be bothersome, impact sleep and affect activities of daily living including school or work.1
About FLONASE® Allergy Relief
FLONASE® Allergy Relief is the first and only non-prescription nasal spray in Canada indicated for relief of both eye-related and nasal allergy symptoms caused by seasonal and year-round allergens, including pollen, mold, dust and pets.2,3 It provides 24 hour, non-drowsy allergy relief of: sneezing, itchy nose and throat, runny nose and itchy, watery eyes, nasal congestion and sinus pain and pressure.2
FLONASE® Allergy Relief acts on six key inflammatory substances including, histamine, chemokines, leukotrienes, cytokines, tryptases and prostaglandins, which are released when the body has an allergic reaction,2 compared to other seasonal allergy treatments, that act on histamines alone*.
FLONASE® Allergy Relief is behind the counter in Quebec. Availability varies by province. Please speak with your pharmacist. To learn more about FLONASE® Allergy Relief, visit www.flonase.ca, or the Facebook page at https://www.facebook.com/flonasecanada.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world’s largest over the-counter consumer healthcare products companies. Its more than 30 well-known brands include Voltaren Emulgel®, Aquafresh®, Sensodyne®, and TUMS® – which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies. These brands are successful in over 100 countries around the world because they all show our passion for quality, guaranteed by science. They are inspired by the real wants and needs of the millions of people who walk into pharmacies, supermarkets, market stalls and go on-line all over the world every day, and choose us first.
GlaxoSmithKline’s goal is to build a global, growing business called Fast Moving Consumer Healthcare (FMCH), dedicated to everyday healthcare with all of the scientific expertise and quality guarantees that demands, working at the speed and with the genuine consumer understanding the modern world expects.
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: https://www.gsk.com.
For further information, please contact:
GSK Consumer Healthcare
1 Keith P, et al. The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allergy Asthma Clin Immunol. 2012; 8(1): 7.
2 FLONASE ® Allergy Relief Product Monograph. GSKCH. Aug 26, 2016.
3 Nasocort® Allergy 24HR Product Monograph. Sanofi-aventis Canada Inc. December 2, 2013.
* Mechanism vs. most OTC allergy pills. FLONASE® Allergy Relief acts on multiple inflammatory substances (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.